Titre : The changing HCV treatment cascade
link : The changing HCV treatment cascade
The changing HCV treatment cascade
Pharmacology Consult
The changing HCV treatment cascade
Infectious Disease News, October 2017
Jocelyn Mason, PharmD; Kimberly D. Boeser, PharmD, MPH, BCPS, AQ-ID
The changing HCV treatment cascade
Infectious Disease News, October 2017
Jocelyn Mason, PharmD; Kimberly D. Boeser, PharmD, MPH, BCPS, AQ-ID
The rapid development of DAA combinations provides simplified regimens, shorter durations, improved efficacy and greater tolerability, unlike the previous interferon and ribavirin cornerstone regimens. Although the IDSA/AASLD guidelines provide the map to managing HCV, they do not identify the ideal interferon-free regimen to begin with, nor have they given a clear path to treating genotype 3 and those with decompensated cirrhosis. This ever-changing field will require collaboration among health care providers, including those specializing in infectious diseases, hepatology and gastroenterology, as well as pharmacists, to optimize treatment strategies. As the landscape of HCV continues to update with new literature and new medications, this subspecialty continues to be dynamic.Continue to article - http://ift.tt/2ghlOpf
Thus articles The changing HCV treatment cascade
that is all articles The changing HCV treatment cascade This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article The changing HCV treatment cascade the link address https://newsaninpiration.blogspot.com/2017/10/the-changing-hcv-treatment-cascade.html
0 Response to "The changing HCV treatment cascade"
Post a Comment